Reprinted from The Los Angeles Times by Melanie Mason on September 6, 2017.
Backers of a measure to require pharmaceutical companies to disclose more information on the list prices of their drugs are stepping up their lobbying efforts in the closing days of the California legislative session.
Labor unions, consumer groups, health plans and other high-profile advocacy organizations such as the AARP and NextGen, which is bankrolled by billionaire activist Tom Steyer, made the rounds at the state Capitol on Wednesday to urge Assembly members to back the bill, SB 17, by state Senator Ed Hernandez (D-West Covina).
Similar measures have faltered in the past, but Hernandez said this year, business-friendly Democrats and some Republicans have signaled an interest in supporting the bill.
“The dynamics and the politics of this have changed dramatically,” he said at a news conference Wednesday. …